Intra-Cellular Therapies, Inc. (ITCI)
NASDAQ: ITCI · Real-Time Price · USD
83.45
-0.69 (-0.82%)
At close: Dec 20, 2024, 4:00 PM
84.32
+0.87 (1.04%)
After-hours: Dec 20, 2024, 4:09 PM EST

Intra-Cellular Therapies Stock Forecast

Stock Price Forecast

The 12 analysts with 12-month price forecasts for ITCI stock have an average target of 97.67, with a low estimate of 74 and a high estimate of 130. The average target predicts an increase of 17.04% from the current stock price of 83.45.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $74 $97.67 $100 $130
Change -11.32% +17.04% +19.83% +55.78%
* Price targets were last updated on Nov 4, 2024.

Analyst Ratings

The average analyst rating for ITCI stock from 12 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jul '24Aug '24Sep '24Oct '24Nov '24Dec '24
Strong Buy 555555
Buy 544555
Hold 222222
Sell 000000
Strong Sell 000000
Total 121111121212

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
JP Morgan
JP Morgan
Buy
Maintains
$81$89
Buy Maintains $81$89 +6.65% Nov 4, 2024
Needham
Needham
Strong Buy
Reiterates
$100
Strong Buy Reiterates $100 +19.83% Oct 31, 2024
Needham
Needham
Strong Buy
Reiterates
$100
Strong Buy Reiterates $100 +19.83% Oct 30, 2024
Morgan Stanley
Morgan Stanley
Buy
Maintains
$92$95
Buy Maintains $92$95 +13.84% Oct 11, 2024
RBC Capital
RBC Capital
Buy
Maintains
$106$108
Buy Maintains $106$108 +29.42% Oct 4, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
688.47M
from 464.37M
Increased by 48.26%
Revenue Next Year
953.21M
from 688.47M
Increased by 38.45%
EPS This Year
-0.71
from -1.46
EPS Next Year
0.28
from -0.71
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
60.61K22.81M83.80M250.31M464.37M688.47M953.21M1.42B
Revenue Growth
-37,537.14%267.35%198.69%85.51%48.26%38.45%48.45%
EPS
-2.68-3.23-3.50-2.72-1.46-0.710.283.64
EPS Growth
-------1,210.66%
Forward PE
------300.7922.95
No. Analysts -----181816
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026202720282029
High 715.1M 1.1B 1.7B
Avg 688.5M 953.2M 1.4B
Low 652.2M 839.9M 1.1B

Revenue Growth

Revenue Growth 202420252026202720282029
High
54.0%
57.9%
79.5%
Avg
48.3%
38.5%
48.4%
Low
40.4%
22.0%
15.5%

EPS Forecast

EPS 202420252026202720282029
High -0.37 1.39 6.33
Avg -0.71 0.28 3.64
Low -1.04 -0.92 1.46

EPS Growth

EPS Growth 202420252026202720282029
High - -
2,182.1%
Avg - -
1,210.7%
Low - -
426.3%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.